Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 28,080 shares at $13.93 ($391K) on 2018-01-08, disclosed to the SEC on 2018-01-12.
Open-market sale of $391k STML by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.93 | 14,040 | $196K | 50.0% |
| 2 | $13.93 | 14,040 | $196K | 50.0% |
| Total | $13.93 avg | 28,080 | $391K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |